Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment pattern

Study identifier:D2287R00139

ClinicalTrials.gov identifier:NCT03963141

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE.

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

40541

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 31 Aug 2019
Primary Completion Date: 31 Oct 2022
Study Completion Date: 31 Oct 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria